147 related articles for article (PubMed ID: 6214446)
81. Mechanism of accumulation of the antitumor protein antibiotic neocarzinostatin in bladder tissue: intravenous administration, urinary excretion, and absorption into bladder tissue.
Maeda H; Sakamoto S; Ogata J
Antimicrob Agents Chemother; 1977 Jun; 11(6):941-5. PubMed ID: 141906
[TBL] [Abstract][Full Text] [Related]
82. Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies.
Gottschalk U; Garnett MC; Ward RK; Maibücher A; Köhnlein W
J Antibiot (Tokyo); 1991 Oct; 44(10):1148-54. PubMed ID: 1835456
[TBL] [Abstract][Full Text] [Related]
83. Stimulation of DNA polymerase beta activity in permeabilized mouse P815 mast cells after neocarzinostatin treatment.
Geurtsen W; Zahn RK; Maidhof A; Müller WE
Gan; 1981 Apr; 72(2):259-63. PubMed ID: 6456962
[TBL] [Abstract][Full Text] [Related]
84. On the mechanism of reductive activation in the mode of action of some anticancer drugs.
Favaudon V
Biochimie; 1982 Jul; 64(7):457-75. PubMed ID: 6181817
[TBL] [Abstract][Full Text] [Related]
85. Mechanism of DNA degradation induced by neocarzinostatin in Bacillus subtilis.
Ohtsuki K; Ishida N
J Antibiot (Tokyo); 1975 Mar; 28(3):229-36. PubMed ID: 123897
[TBL] [Abstract][Full Text] [Related]
86. Evaluation of succinyl neocarzinostatin in vivo.
Maeda H; Ichimura H; Satoh H; Ohtsuki K
J Antibiot (Tokyo); 1978 May; 31(5):468-72. PubMed ID: 149781
[TBL] [Abstract][Full Text] [Related]
87. Fate and distribution of [14C] succinyl neocarzinostatin in rats.
Maeda H; Yamamoto N; Yamashita A
Eur J Cancer (1965); 1976 Nov; 12(11):865-70. PubMed ID: 136355
[No Abstract] [Full Text] [Related]
88. Degradation of neocarzinostatin by blood sera in vitro and its inhibition by diisopropyl fluorophosphate and n-ethylmaleimide.
Maeda H; Takeshita J
Gan; 1975 Oct; 66(5):523-7. PubMed ID: 130275
[TBL] [Abstract][Full Text] [Related]
89. Enzyme-linked immunosorbent assay of neocarzinostatin chromophore (NCS-chr) by use of a monoclonal antibody against NCS-chr analog.
Mizugaki M; Itoh K; Nakamura H; Ishida N
J Immunoassay; 1996 May; 17(2):133-44. PubMed ID: 8744283
[TBL] [Abstract][Full Text] [Related]
90. The biologically active site of neocarzinostatin-chromophore.
Koide Y; Ito A; Edo K; Ishida N
Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4425-8. PubMed ID: 2951017
[No Abstract] [Full Text] [Related]
91. [Pharmacokinetics of neocarzinostatin in patients with malignant glioma. Quantitative analysis of tissue concentration].
Otsuka T; Matsukado Y; Uemura S; Kuratsu J; Sonoda H; Mihara Y; Goto S
Neurol Med Chir (Tokyo); 1989 Jun; 29(6):471-5. PubMed ID: 2479848
[TBL] [Abstract][Full Text] [Related]
92. Clinical pharmacology of the anticancer polypeptide neocarzinostatin.
Hall SW; Knight J; Broughton A; Benjamin RS; McKelvey E
Cancer Chemother Pharmacol; 1983; 10(3):200-4. PubMed ID: 6222845
[TBL] [Abstract][Full Text] [Related]
93. Clinical investigations of neocarzinostatin in Japan.
Kimura I
Recent Results Cancer Res; 1978; 63():252-60. PubMed ID: 151899
[TBL] [Abstract][Full Text] [Related]
94. Studies on the interaction of neocarzinostatin with rat liver DNA in vivo and in vitro.
Sarma DS; Rajalakshmi S
Biochem Pharmacol; 1976 Apr; 25(7):789-92. PubMed ID: 132933
[No Abstract] [Full Text] [Related]
95. Single-strand nicking of DNA in vitro by neocarzinostatin and its possible relationship to the mechanism of drug action.
Beerman TA; Poon R; Goldberg IH
Biochim Biophys Acta; 1977 Mar; 475(2):294-306. PubMed ID: 139167
[TBL] [Abstract][Full Text] [Related]
96. Activation of neocarzinostatin chromophore and formation of nascent DNA damage do not require molecular oxygen.
Kappen LS; Goldberg IH
Nucleic Acids Res; 1985 Mar; 13(5):1637-48. PubMed ID: 3158880
[TBL] [Abstract][Full Text] [Related]
97. An uptake of fluorescein isothiocyanate labeled neocarzinostatin into the cancer and normal cells.
Sakamoto S; Maeda H; Ogata J
Experientia; 1979 Sep; 35(9):1233-5. PubMed ID: 158538
[TBL] [Abstract][Full Text] [Related]
98. Reduced bone marrow toxicity of neocarzinostatin by conjugation with divinyl ether-maleic acid copolymer.
Yamamoto H; Miki T; Oda T; Hirano T; Sera Y; Akagi M; Maeda H
Eur J Cancer; 1990 Mar; 26(3):253-60. PubMed ID: 2141482
[TBL] [Abstract][Full Text] [Related]
99. The promoting effect of amphotericin B on the incorporation of neocarzinostatin into human gastric cancer tissue.
Nakazawa I; Ouchi E; Ishida N; Takano S; Ouchi K; Wagai K
Tohoku J Exp Med; 1980 May; 131(1):101-2. PubMed ID: 6447386
[TBL] [Abstract][Full Text] [Related]
100. A model for the activation and inactivation of neocarzinostatin, an antitumor protein.
Lewis RS; Jung G; Köhnlein W
Biochim Biophys Acta; 1980 Jun; 608(1):138-46. PubMed ID: 6446321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
